Further point - I am no trial expert and have only my learned experience from NEU to comment - NEU we’re dealing with a condition which is rare and therefore with limited patient numbers.
I do believe our trials will be “easier” if that makes sense, as they won’t be blinded, and will have higher patient numbers to call upon.
Maybe we can negotiate the complexities I mentioned earlier ourselves?
My preference would be to do do if we can, including sskes etc - just not sure how feasible that really is.,
- Forums
- ASX - By Stock
- Ann: FDA Clears PYC to Commence First Human Trials in RP11
PYC
pyc therapeutics limited
Add to My Watchlist
3.54%
!
$1.17

Further point - I am no trial expert and have only my learned...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.17 |
Change
0.040(3.54%) |
Mkt cap ! $670.7M |
Open | High | Low | Value | Volume |
$1.15 | $1.17 | $1.11 | $96.90K | 85.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 652 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 717 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 652 | 1.160 |
2 | 5044 | 1.155 |
1 | 2647 | 1.150 |
1 | 2073 | 1.145 |
2 | 2499 | 1.140 |
Price($) | Vol. | No. |
---|---|---|
1.170 | 717 | 2 |
1.175 | 9809 | 2 |
1.180 | 20836 | 4 |
1.185 | 410 | 1 |
1.190 | 426 | 1 |
Last trade - 13.07pm 20/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |